Obesity and multiple myeloma

Tracey Beason, Graham Colditz

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

10 Scopus citations

Abstract

Multiple myeloma (MM) is a plasma B-cell malignancy that is characterized by the presence of clonal proliferation of malignant plasma cells in the bone marrow, monoclonal protein in blood or urine, and organ dysfunction. It accounts for 10% of hematological malignancies and approximately 1% of all cancers in the USA. Several etiologic agents are associated with its development. Notably, obesity is consistently associated with increased risk and drives mechanistic pathways important in its development. In addition to age, black or African American heritage is a consistent risk factor as is male gender. Epidemiologic evidence on causes and biologic pathways supporting the obesity relation are presented. Diagnosis and treatment of MM patients are considered in the context of obesity as a cause with potential impact on treatment and outcomes among those with disease.

Original languageEnglish
Title of host publicationEnergy Balance and Hematologic Malignancies
PublisherSpringer US
Pages71-95
Number of pages25
ISBN (Electronic)9781461424031
ISBN (Print)9781461424024
DOIs
StatePublished - Jan 1 2012

Fingerprint Dive into the research topics of 'Obesity and multiple myeloma'. Together they form a unique fingerprint.

Cite this